Nearly 20M Hydroxychloroquine Tablets Head To Cities Across U.S.

The strategic national stockpile has distributed 19.1 million hydroxychloroquine tablets, primarily used for malaria and autoimmune diseases, but controversially suggested for COVID-19 treatment. Despite President Trump's endorsement, evidence of its effectiveness against COVID-19 is lacking, and scientists advise caution. FEMA has shipped nine million tablets to major cities like New York and Chicago, with additional shipments to other cities and organizations like Veterans Affairs and the Department of Defense. The total supply could treat approximately 1.4 million patients.

What is hydroxychloroquine primarily used to treat?

• COVID-19

• Common cold

• Heart diseases

• Malaria and autoimmune diseases

Why have scientists advised caution in using hydroxychloroquine for COVID-19?

• It is too expensive

• It is not available in sufficient quantities

• Its effectiveness and safety for COVID-19 are not yet proven

• It is only effective for children

Which cities received the first shipment of hydroxychloroquine tablets?

• New York City, Chicago, New Orleans, Detroit

• Boston, Miami, Atlanta

• Los Angeles, San Francisco, Seattle

• Houston, Dallas, Austin

What additional support will the hydroxychloroquine shipment provide?

• Private hospitals

• International aid organizations

• Veterans Affairs and Department of Defense

• Local pharmacies

How many patients could potentially be treated with the distributed tablets?

• 2 million

• 3.5 million

• 1.4 million

• 500,000